Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06796738 · ClinicalTrials.gov registry record · NA
Advancing Cervical Cancer Screening Through the Emergency Department - IIS
A NA study of Hpv and Cervical Cancers, sponsored by University of Rochester.
- Active
- Registry status
- NA
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT06796738: Active NA study of Hpv and Cervical Cancers, sponsored by University of Rochester.
NCT06796738 is a NA study of Hpv and Cervical Cancers that is active but no longer recruiting, run by University of Rochester. The registered enrollment target is 200 participants, below the 2,233-participant average among 24 other Hpv trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06796738, a NA study of Hpv and Cervical Cancers, is active but no longer recruiting, sponsored by University of Rochester.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
Cervical cancer screening in the Emergency Department
Primary Outcome
All intervention participants will receive a follow-up call at 150 days to assess uptake of any cervical cancer screening and for completion of the cervical cancer screening process. "Any cervical cancer screening" is defined as uptake of any aspect of the cervical cancer screening process, including self-sampling and/or clinic-based screening. "Completion of the cervical cancer screening process" is defined as completion of recommended clinic-based screening (including colposcopy if HPV 16/18+
Conditions Studied
Interventions
- DIAGNOSTIC_TEST HPV testing
Study Locations (1)
New York
- University of Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-06-13 |
| Est. Completion | 2027-03-01 |
| Phase | NA |
What the registry record for NCT06796738 still lists
NCT06796738 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 2,233-participant average among 24 other Hpv trials with a reported enrollment target (91% lower).
The record links to 2 conditions, with Hpv appearing as the primary indexed condition, and to 1 intervention - of which HPV testing is the first listed.
NCT06796738 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06796738 about?
NCT06796738 is a clinical study titled "Advancing Cervical Cancer Screening Through the Emergency Department - IIS". Cervical cancer screening in the Emergency Department
What is the current status of trial NCT06796738?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2025-06-13. Estimated completion is 2027-03-01.
What conditions does trial NCT06796738 study?
This clinical trial studies the following conditions: Hpv, Cervical Cancers.
What interventions are being tested in trial NCT06796738?
The interventions under investigation include: HPV testing (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06796738?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06796738 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hpv
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06796738's enrollment target sits among peer trials
200 12th of 24 higher than 13 of 24 other Hpv trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hpv trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination
RECRUITING · NA
-
HPV Self-Collection Program
RECRUITING · NA
-
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
RECRUITING · NA
-
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
RECRUITING · NA
-
Playing Game to Learn About Children's Vaccine Project
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI